Mysildecard (Sildenafil)

Sildenafil blocks phosphodiesterase type 5, an enzyme that degrades cyclic GMP. By preserving cyclic GMP, the drug promotes smooth‑muscle relaxation in the corpus cavernosum and pulmonary arteries, which increases blood flow and supports erection or lowers pulmonary arterial pressure.

The appropriate dose of Mysildecard is determined by the prescribing clinician based on the individual’s medical condition, response to therapy and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Sildenafil is not recommended for use during pregnancy or while breastfeeding unless the benefits clearly outweigh the risks and a healthcare professional advises otherwise. Safety data in these populations are limited, so a prescriber should evaluate each case individually.

To request Mysildecard, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mysildecard (sildenafil) belongs to the same class as tadalafil and vardenafil. All share the PDE5‑inhibition mechanism, but they differ in duration of action, dosing frequency and specific side‑effect profiles. Choice of agent depends on patient preference, clinical response and physician judgment.

Mysildecard should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Do not store in bathrooms or near heat sources to maintain product stability.

Mysildecard is taken orally, usually with water, and can be taken with or without food. The exact timing relative to sexual activity or daily dosing for pulmonary hypertension is directed by the prescribing clinician.

Serious risks include priapism (a prolonged erection lasting more than four hours), sudden loss of vision, and sudden loss of hearing. Any of these events require immediate medical attention. Patients with significant cardiovascular disease should also be evaluated carefully.

Mysildecard should not be used by individuals taking nitrates, those with severe hypotension, recent myocardial infarction, uncontrolled hypertension, or known hypersensitivity to sildenafil or any tablet excipients. A healthcare professional should assess suitability before prescribing.